Literature DB >> 3118240

Minimal thyroid ophthalmopathy.

R H Spector1, J A Carlisle.   

Abstract

We studied six patients with the clinical, sonographic, CT, and biochemical profile of minimal euthyroid Graves' disease (MEGD). This syndrome was characterized clinically by small but obtrusive and measurable amounts of diplopia related to endocrine ophthalmopathy and the conspicuous absence of systemic or laboratory signs of thyrotoxicosis. Diagnostic emphasis will be given to certain manifestations of MEGD, namely the clinical patterns of ophthalmoparesis, the results of forced duction testing, orbital ultrasonography, and CT, as well as the need to obtain, in some cases, special antibody studies and the thyrotropin releasing hormone stimulation test.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118240     DOI: 10.1212/wnl.37.11.1803

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Recurrent external ophthalmoparesis during hormonal therapy after thyroid ablation. Case report.

Authors:  F Ferracci; F Conte; B Marini; G Fassetta
Journal:  Ital J Neurol Sci       Date:  1997-08

2.  [Ocular myositis as a rare cause of vision loss].

Authors:  J D Rollnik; H Requadt
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 3.  Investigation of visual loss: neuro-ophthalmology from a neurologist's perspective.

Authors:  C J Lueck
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.